BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Çoban A, Bilgiç B, Lohmann E, Küçükali Cİ, Benbir G, Karadeniz D, Hanagasi HA, Tüzün E, Gürvit H. Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am J Alzheimers Dis Other Demen 2013;28:606-11. [PMID: 23813609 DOI: 10.1177/1533317513494453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci 2016;39:552-66. [PMID: 27325209 DOI: 10.1016/j.tins.2016.05.002] [Cited by in Crossref: 201] [Cited by in F6Publishing: 179] [Article Influence: 33.5] [Reference Citation Analysis]
2 Nassan M, Videnovic A. Circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 2021. [PMID: 34759373 DOI: 10.1038/s41582-021-00577-7] [Reference Citation Analysis]
3 Herrmann O, Ficek B, Webster KT, Frangakis C, Spira AP, Tsapkini K. Sleep as a predictor of tDCS and language therapy outcomes. Sleep 2021:zsab275. [PMID: 34875098 DOI: 10.1093/sleep/zsab275] [Reference Citation Analysis]
4 Liguori C, Romigi A, Mercuri NB, Nuccetelli M, Izzi F, Albanese M, Sancesario G, Martorana A, Sancesario GM, Bernardini S, Marciani MG, Placidi F. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia. J Neurol 2014;261:1832-6. [DOI: 10.1007/s00415-014-7455-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
5 Gan J, Chen Z, Han J, Ma L, Liu S, Wang XD, Ji Y. Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:765701. [PMID: 34867809 DOI: 10.3389/fendo.2021.765701] [Reference Citation Analysis]
6 Hwang YT, Piguet O, Hodges JR, Grunstein R, Burrell JR. Sleep and orexin: A new paradigm for understanding behavioural-variant frontotemporal dementia? Sleep Medicine Reviews 2020;54:101361. [DOI: 10.1016/j.smrv.2020.101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC. Physiological changes in neurodegeneration - mechanistic insights and clinical utility. Nat Rev Neurol 2018;14:259-71. [PMID: 29569624 DOI: 10.1038/nrneurol.2018.23] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
8 Bhat S, Chokroverty S. Hypersomnia in Neurodegenerative Diseases. Sleep Med Clin 2017;12:443-60. [PMID: 28778241 DOI: 10.1016/j.jsmc.2017.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
9 Stern AL, Naidoo N. Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. Springerplus 2015;4:25. [PMID: 25635245 DOI: 10.1186/s40064-014-0777-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
10 Liu J, Guo Z, Yan X, Yang Y, Huang S. Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1. Front Aging Neurosci 2021;13:755392. [DOI: 10.3389/fnagi.2021.755392] [Reference Citation Analysis]
11 Sani TP, Bond RL, Marshall CR, Hardy CJD, Russell LL, Moore KM, Slattery CF, Paterson RW, Woollacott IOC, Wendi IP, Crutch SJ, Schott JM, Rohrer JD, Eriksson SH, Dijk DJ, Warren JD. Sleep symptoms in syndromes of frontotemporal dementia and Alzheimer's disease: A proof-of-principle behavioural study. eNeurologicalSci 2019;17:100212. [PMID: 31828228 DOI: 10.1016/j.ensci.2019.100212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Holth J, Patel T, Holtzman DM. Sleep in Alzheimer's Disease - Beyond Amyloid. Neurobiol Sleep Circadian Rhythms 2017;2:4-14. [PMID: 28217760 DOI: 10.1016/j.nbscr.2016.08.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 12.0] [Reference Citation Analysis]
13 McCarter SJ, St Louis EK, Boeve BF. Sleep Disturbances in Frontotemporal Dementia. Curr Neurol Neurosci Rep 2016;16:85. [PMID: 27485946 DOI: 10.1007/s11910-016-0680-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
14 Ahmed RM, Halliday G, Hodges JR. Hypothalamic symptoms of frontotemporal dementia disorders. Handb Clin Neurol 2021;182:269-80. [PMID: 34266598 DOI: 10.1016/B978-0-12-819973-2.00019-8] [Reference Citation Analysis]
15 Warren JD, Clark CN. A new hypnic paradigm of neurodegenerative proteinopathies. Sleep Medicine 2017;32:282-3. [DOI: 10.1016/j.sleep.2016.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Heywood WE, Hallqvist J, Heslegrave AJ, Zetterberg H, Fenoglio C, Scarpini E, Rohrer JD, Galimberti D, Mills K. CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging 2018;72:171-6. [PMID: 30292090 DOI: 10.1016/j.neurobiolaging.2018.08.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]